Aurinia制药 AUPH 深 沪
已收盘 07-18 16:00:00 美东时间
8.63
-0.440
-4.85%
华盛通- 最 高9.13
- 今 开9.06
- 成交量 200.55万股
- 最 低 8.61
- 昨 收 9.07
- 总市值 11.65亿
- 52周最高 10.67
- 市盈率 静 219.59
- 换手率 1.49%
- 52周最低 5.195
- 委 比 22.97%
- 总股本 1.35亿
- 历史最高 33.972
- 量 比 1.15
- 振 幅 5.73%
- 历史最低 1.41
- 每 手 1
- 风险率 1.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股周涨跌榜 | Blue Gold上市暴涨近10倍！脑再生科技反弹32%，指责卖空者导致股价巨震
金矿股Blue Gold上市暴涨近10倍！脑再生科技周内反弹32%，公司指责卖空者导致其股价剧烈波动>>
07-04 19:30
Aurinia Pharmaceuticals to Discuss AUR200 Phase 1 Study Results
Aurinia Pharmaceuticals ( ($AUPH) ) just unveiled an update. Aurinia Pharmaceut...
06-30 05:32
US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert
U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of benchmark indices were mixed in premarket.
05-23 18:15
Aurinia Pharmaceuticals Q1 2025 Earnings: Strong Growth Amid Challenges
Aurinia Pharmaceuticals (($AUPH)) has held its Q1 earnings call. Read on for th...
05-13 08:24
Aurinia Pharma Swings Into Profit As Q1 Sales Jumps 24%, Sticks To Guidance
Aurinia posts Q1 profit and 25% LUPKYNIS sales growth, reports $62.47 million revenue, and reaffirms full-year guidance.
05-13 00:56
Aurinia Pharmaceuticals Affirms FY2025 Sales Guidance of $250.00M-$260.00M vs $257.87M Est
Aurinia Pharmaceuticals (NASDAQ:AUPH) affirms FY2025 sales outlook from $250.00 million-$260.00 million to $250.00 million-$260.00 million vs $257.87 million estimate.
05-12 18:03
Aurinia Pharmaceuticals Q1 EPS $0.16 Beats $0.10 Estimate, Sales $62.47M Beat $61.54M Estimate
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.10 by 60 percent. This is a 328.57 percent increase over losses of $(0.07) per share
05-12 18:01
Earnings Scheduled For May 12, 2025
Companies Reporting Before The Bell • Superior Industries Intl (NYSE:SUP) is pr...
05-12 16:32
Insider Moves: Semtech, BioMarin, Yum!, Tenaya, Aurinia
Insiders have been trading these 5 stocks: (($SMTC)), (($BMRN)), (($YUM)), (($T...
03-08 21:04
Aurinia Pharmaceuticals stock climbs on insider buying
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares rose about 7% in morning trade after its Director, Kevin Tang, disclosed purchase of company stocks. Tang disclosed three transactions with the SEC, buying...
03-05 23:57
